![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Pharma Blog Watch
Pharma Blog Watch
August 4, 2006
Lipitor Patent
Suit (Patent Baristas)
In his entry, Stephen Albainy-Jenei discusses Pfizer's patent infringement suit
against Ranbaxy over Lipitor, and how the dependent claim form played a large
role in the case.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
21Oct